Home About Us Writing a Scientific Article Author's Instruction Contact us



/  /    MRJMMS Home   /   /    About MRJMMS    /  /    Submit Manuscripts    /  /      Call For Articles      / /     Editorial Board     / /    Archive     / /    Author's Guide  /  /


November 2019 Vol. 7 No.11

Other viewing option

Full text
Reprint (PDF) (315 KB)

Search Pubmed for articles by:

Sapira V
Lungu M

Other links:
PubMed Citation
Related articles in PubMed



Merit Research Journal of Medicine and Medical Sciences (ISSN: 2354-323X) Vol. 7(11) pp. 456-460, November, 2019 

Copyright © 2019 Merit Research Journals
DOI: 10.5281/zenodo.3556828

Case Report

Amiodarone – a rare cause of acute hepatitis – case presentation


Violeta Sapira1, Anca Telehuz2, Mihai Polinschi3, Alexandru Nechifor3, Valerica Zarnescu Creanga3 and
Mihaela Lungu1*


1Emergency Clinical County Hospital “Sfantul Apostol Andrei” Galati, “Dunarea de Jos” University of Galati
2Slobozia Emergency County Hospital, Romania
3“Faculty of Medicine and Pharmacy, “Dunarea de Jos” University of Galati, Romania

*Corresponding Author’s E-mail: micalungu@gmail.com

Accepted November 27, 2019




Amiodarone, a Class III antiarrhythmic agent, used in the treatment of supraventricular and ventricular tachyarrhythmias, may cause acute hepatitis. Although it is a rare complication, it can be fatal. We presented the case of a 59-year-old patient without any personal pathological background, chronic medication and cardiovascular risk factors, who came in the emergency Department where he is diagnosed with atrial fibrillation. Intravenous amiodarone treatment is instituted, but at 12 hours after initiation of treatment, there is a significant increase in the level of hepatic transaminases. The diagnosis of acute hepatitis is made, possibly drug-related. After we stopped the amiodarone administration, the evolution is favorable, with the remission of the cytolysis syndrome. This case highlights the need for careful monitoring of patients receiving intravenous amiodarone to identify any potential for hepatotoxicity.

Keywords: Intravenous amiodarone, acute hepatotoxicity, hepatic transaminases, amiodarone induced liver injury









Merit Research Journals© 2019 || Advertisement | Privacy policy.